We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
Cap. Flow
+$405M
Cap. Flow %
6.29%
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$330M
2
BKD icon
Brookdale Senior Living
BKD
+$93.7M
3
THC icon
Tenet Healthcare
THC
+$85.2M
4
ENDP
Endo International plc
ENDP
+$70.6M
5
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$64.3M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$206M
2
CVS icon
CVS Health
CVS
+$122M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$102M
4
MCK icon
McKesson
MCK
+$80.6M
5
PCRX icon
Pacira BioSciences
PCRX
+$45.1M

Sector Composition

Rank Sector Weight
1 Healthcare 49.63%
2 Energy 5.88%
3 Consumer Discretionary 5.63%
4 Financials 4.88%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DS
26
DELISTED
Drive Shack Inc.
DS
$36.9M 0.57%
7,156,700
+446,422
+7% +$2.26M
ZBH icon
27
Zimmer Biomet
ZBH
$18.7B
$35.8M 0.56%
355,036
+229,673
+183% +$22.4M
SU icon
28
Suncor Energy
SU
$77.5B
$35.3M 0.55%
826,968
-28,142
-3% -$1.1M
ELOS
29
DELISTED
Syneron Medical Ltd
ELOS
$35.2M 0.55%
3,410,000
– –
NPSP
30
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$33.7M 0.52%
+1,020,622
New +$29.5M
NVDQ
31
DELISTED
Novadaq Technologies Inc.
NVDQ
$33M 0.51%
2,000,000
+600,000
+43% +$9.88M
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
$32.7M 0.51%
789,933
-369,690
-32% -$19M
OCR
33
DELISTED
OMNICARE INC
OCR
$31.9M 0.5%
479,322
+86,800
+22% +$5.39M
RPRX
34
DELISTED
Repros Therapeutics Inc.
RPRX
$31.8M 0.49%
1,840,799
– –
TMO icon
35
Thermo Fisher Scientific
TMO
$213B
$31.6M 0.49%
267,898
-21,336
-7% -$2.51M
ICLR icon
36
Icon
ICLR
$13.9B
$29.9M 0.46%
634,056
+39,695
+7% +$1.71M
VIRX
37
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$29.5M 0.46%
21,556
– –
ENZY
38
DELISTED
Enzymotec Ltd
ENZY
$28.5M 0.44%
2,100,000
+960,000
+84% +$16.1M
ITMN
39
DELISTED
INTERMUNE INC
ITMN
$27.9M 0.43%
631,255
+28,799
+5% +$1.06M
CTRX
40
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$26.7M 0.42%
605,671
+73,551
+14% +$3.11M
QLTI
41
DELISTED
QLT Inc
QLTI
$26.7M 0.41%
4,319,400
-115,600
-3% -$640K
NBIX icon
42
Neurocrine Biosciences
NBIX
$18.3B
$26.5M 0.41%
1,784,421
-216,514
-11% -$3.06M
NEE icon
43
NextEra Energy
NEE
$185B
$26.2M 0.41%
1,021,244
-521,956
-34% -$12.7M
FLNA
44
Filana Therapeutics
FLNA
$42.3M
$25M 0.39%
621,429
– –
RGLD icon
45
Royal Gold
RGLD
$16.6B
$24.9M 0.39%
326,594
+138,606
+74% +$9.16M
DVN icon
46
Devon Energy
DVN
$51B
$22.6M 0.35%
+285,085
New +$20.7M
PTR
47
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$22M 0.34%
175,143
+47,097
+37% +$5.55M
TWC
48
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$21.9M 0.34%
148,556
-9,225
-6% -$1.29M
EXC icon
49
Exelon
EXC
$48.2B
$21.5M 0.33%
827,557
+800,205
+2,926% +$20.4M
TFCF
50
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$21.2M 0.33%
620,237
+350,925
+130% +$11.6M
1
2
3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Visium Asset Management deployed $405M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.

  • Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
  • Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
  • Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
  • Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
  • Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
  • Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
  • Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.

Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.